Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic Target. | Cancers (Basel) | 2021 | 33669398 | PubTator, text mining | PubMed |
| Barrier-to-autointegration-factor (Banf1) modulates DNA double-strand break repair pathway choice via regulation of DNA-dependent kinase (DNA-PK) activity. | Nucleic Acids Res | 2021 | 33660778 | PubTator, text mining | PubMed |
| Gene Targeting Facilitated by Engineered Sequence-Specific Nucleases: Potential Applications for Crop Improvement. | Plant Cell Physiol | 2021 | 33638992 | PubTator, text mining | PubMed |
| Exosome-mediated cellular crosstalk within the tumor microenvironment upon irradiation. | Cancer Biol Med | 2021 | 33628582 | PubTator, text mining | PubMed |
| Rare Variants in the DNA Repair Pathway and the Risk of Colorectal Cancer. | Cancer Epidemiol Biomarkers Prev | 2021 | 33627384 | PubTator, text mining | PubMed |
| Microbial single-strand annealing proteins enable CRISPR gene-editing tools with improved knock-in efficiencies and reduced off-target effects. | Nucleic Acids Res | 2021 | 33619540 | PubTator, text mining | PubMed |
| Systematic assessment of outcomes following a genetic diagnosis identified through a large-scale research study into developmental disorders. | Genet Med | 2021 | 33603196 | PubTator, text mining | PubMed |
| Downregulation of DNA ligases in trophoblasts contributes to recurrent pregnancy loss through inducing DNA damages. | Placenta | 2021 | 33601221 | PubTator, text mining | PubMed |
| DNA ligase I fidelity mediates the mutagenic ligation of pol β oxidized and mismatch nucleotide insertion products in base excision repair. | J Biol Chem | 2021 | 33600799 | PubTator, text mining | PubMed |
| Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal. | Front Immunol | 2021 | 33597956 | PubTator, text mining | PubMed |
| Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining. | Cancer Res | 2021 | 33597272 | PubTator, text mining | PubMed |
| Hypomorphic mutations in human DNA ligase IV lead to compromised DNA binding efficiency, hydrophobicity and thermal stability. | Protein Eng Des Sel | 2021 | 33586762 | Swiss-Prot, curated | PubMed |
| Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes. | Mol Ther Nucleic Acids | 2021 | 33575113 | PubTator, text mining | PubMed |
| Enhancing CRISPR deletion via pharmacological delay of DNA-PKcs. | Genome Res | 2021 | 33574136 | PubTator, text mining | PubMed |
| Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types. | Sci Transl Med | 2021 | 33568520 | PubTator, text mining | PubMed |
| Herpes Simplex Virus 1 Manipulates Host Cell Antiviral and Proviral DNA Damage Responses. | mBio | 2021 | 33563816 | PubTator, text mining | PubMed |
| Repair of DNA Double-Strand Breaks by the Nonhomologous End Joining Pathway. | Annu Rev Biochem | 2021 | 33556282 | PubTator, text mining | PubMed |
| SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors. | Proc Natl Acad Sci U S A | 2021 | 33536335 | PubTator, text mining | PubMed |
| Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells. | J Clin Med | 2021 | 33535527 | PubTator, text mining | PubMed |
| Whole-genome characterization of lung adenocarcinomas lacking the RTK/RAS/RAF pathway. | Cell Rep | 2021 | 33535033 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=47